The Treatment and Natural History of Acromegaly
Public ClinicalTrials.gov record NCT00001981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Acromegaly Treatment and Natural History
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to acromegaly.
Study identification
- NCT ID
- NCT00001981
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 117 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 1, 1991
- Primary completion
- Nov 19, 2020
- Completion
- Nov 19, 2020
- Last update posted
- Nov 26, 2020
1991 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Acromegaly trials
Other public records listing Acromegaly. Sorted by last update posted; newest first. Not a recommendation.
- NCT07641179: A Study to Evaluate MAR002 for Acromegaly Recruiting
- NCT05192382: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) Active, not recruiting
- NCT04837040: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly Active, not recruiting
- NCT06930625: A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs Recruiting
- NCT07037420: ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly Recruiting
- NCT07195175: Study of MAR002 in Healthy Men Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00001981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2020 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00001981 live on ClinicalTrials.gov.